Grace Therapeutics, Inc. Common Stock
$2.140
USD
Last updated on --.
24h volume355.00
24h highest2.1750 USD
24h lowest2.1370 USD
24h Price movement+0.94%
GRCE recent prices
24 Hours
+0.94%+$0.02
30 days
-14.06%-$0.35
60 days
-6.96%-$0.16
90 days
-8.55%-$0.2
Key data
Previous close2.1200 USD
Market cap33.69M USD
Volume355.00
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.48000 USD
Net income (FY)-7.79M USD
Revenue (FY)--
Last report dateJun 18, 2026
About Grace Therapeutics, Inc. Common Stock
HeadquartersPRINCETON
Employees (FY)5.00
Net income per employee (FY)-1.56M USD
Listed onNasdaq
GRCE conversion tables
 |  |
|---|---|
| 0.5 GRCE | 1.070 USD |
| 1 GRCE | 2.140 USD |
| 5 GRCE | 10.7 USD |
| 10 GRCE | 21.4 USD |
| |
|---|---|
| 0.5 USD | 0.23364 GRCE |
| 1 USD | 0.46729 GRCE |
| 5 USD | 2.336 GRCE |
| 10 USD | 4.672 GRCE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
GRCE is trading at $2.140, +0.94% over the last 24 hours. Track live moves on the price chart at the top of this page.
The GRCE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GRCE is currently trading at $2.140, +0.94% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GRCE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GRCE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GRCE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GRCE's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Grace Therapeutics, Inc. Common Stock's market cap is currently 33.69M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume355.00
24h highest2.1750 USD
24h lowest2.1370 USD
24h Price movement+0.94%
Start trade with GRCE Perpetual
Sign up to trade